Latest news with #AnupamRasayanIndia
Business Standard
3 days ago
- Business
- Business Standard
Anupam Rasayan Q1 PAT climbs 768% YoY to Rs 34 cr
Anupam Rasayan India reported 768.36% surge in consolidated net profit to Rs 34.04 crore in Q1 FY26 as against Rs 3.92 crore in Q1 FY25. Revenue from operations rose 91.12% to Rs 485.83 crore in the quarter ended 30 June 2025. Profit before tax stood at Rs 62.85 crore in Q1 FY26, registering the growth of 287.48%, compared with Rs 16.22 crore posted in the corresponding quarter last year. EBITDA (incl. other income) was at Rs 129.2 crore in Q1 FY26 as compared to Rs 59.2 crore in Q1 FY25, up 118% and this would translate into 26% EBITDA margin in this quarter. Total expenses spiked 75.32% year on year to Rs 427.89 crore during the quarter. cost of materials consumed stood at Rs 361.20 crore (up 97.66% YoY), while employee benefits expense was at Rs 20.33 crore (up 19.87% YoY) during the period under review. Anand Desai, managing director of Anupam Rasayan, commented, During Q1 FY26, consolidated revenue stood at Rs 491 crore, registering a robust growth of 89% year-on-year. We strongly believe that the sectoral trends are in our favour, and we are witnessing a clear resurgence in growth. Our pharma and polymer businesses are performing well, coupled with recovery in Agrochemical segment. The USA and Japan markets have shown encouraging trends for Anupam Rasayan. During Q1FY26, total exports accounted for 58% of the total revenue from operations. With the two new agreements signed with Japanese and US-based multinational companies, our order book now stands at Rs 14,646 crore, reflecting the strong growth momentum in our business. Anupam Rasayan India (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Polymer Additives. The company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 75 domestic and international customers, including 31 multinational companies. The counter rose 0.49% to Rs 1,154.10 on the BSE.
Business Standard
3 days ago
- Business
- Business Standard
Anupam Rasayan India consolidated net profit rises 768.37% in the June 2025 quarter
Sales rise 91.12% to Rs 485.83 crore Net profit of Anupam Rasayan India rose 768.37% to Rs 34.04 crore in the quarter ended June 2025 as against Rs 3.92 crore during the previous quarter ended June 2024. Sales rose 91.12% to Rs 485.83 crore in the quarter ended June 2025 as against Rs 254.20 crore during the previous quarter ended June 2024. Particulars Quarter Ended Jun. 2025 Jun. 2024 % Var. Sales 485.83254.20 91 OPM % 25.5820.92 - PBDT 93.5336.86 154 PBT 62.8516.22 287 NP 34.043.92 768
Business Standard
30-07-2025
- Business
- Business Standard
Board of Anupam Rasayan approves issuance of corporate guarantee of USD 17 million
At meeting held on 30 July 2025 The Board of Anupam Rasayan India at its meeting held on 30 July 2025 has approved to provide the corporate guarantee in favour of Export-Import Bank of India for securing the credit facility amounting to USD 17 Million being availed by Anupam General Trading FZE, a wholly-owned subsidiary of the Company.
Business Standard
26-05-2025
- Business
- Business Standard
Anupam Rasayan rises after Q4 PAT climbs 44% YoY to Rs 45 cr
Anupam Rasayan India rose 2.41% to Rs 687.60 after the company's consolidated net profit surged 44.19% to Rs 44.57 crore on a 24.72% jump in revenue from operations to Rs 500.16 crore in Q4 FY25 over Q4 FY24. Profit before tax stood at Rs 88.12 crore in Q4 FY25, registering the growth of 52.16%, compared with Rs 57.91 crore posted in the corresponding quarter last year. EBITDA (including other income) was at Rs 150 crore in Q4 FY25 as compared to Rs 104.7 crore in Q4 FY24, up 43%, and this would translate into 30% EBITDA margin in this quarter. Total expenses rose 17.58% year on year to Rs 417.58 crore during the quarter. cost of materials consumed stood at Rs 282.97 crore (up 119.61% YoY), while employee benefits expense was at Rs 18.41 crore (up 8.35% YoY) during the period under review. On a full-year basis, the company's consolidated net profit fell 27.41% to Rs 93.35 crore on 2.58% decrease in revenue to Rs 1,436.97 crore in FY25 over FY24. Anand Desai, managing director of Anupam Rasayan, commented, Consolidated revenue for the quarter Q4 FY25 stood at Rs 506 crore registering a growth of 22% YoY and 31% QoQ. Consolidated revenue for the full year FY25 stood at Rs 1,448 crore registering a degrowth of 4% YoY. This performance was supported by growth in pharma and polymer coupled with strong performance from Tanfac. Margins have remained consistent this quarter, reflecting our focus on operational efficiency and a favorable product mix. While H1 FY25 was subdued due to weak macro conditions, I am pleased to share that H2 has shown clear signs of recovery particularly in Q4 FY25 where we have seen meaningful improvement with sales increasing both yearon-year and sequentially. We remain confident in our ability to return to the historical growth rates achieved prior to the recent slowdown. Anupam Rasayan India is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Its business verticals are life science-related specialty chemicals, comprising products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, comprising specialty pigments and dyes and polymer additives.
Business Upturn
26-05-2025
- Business
- Business Upturn
Anupam Rasayan India shares jump over 3% as Q4 EBITDA rises 55.70% YoY to Rs Rs 144.3 crore
By Aman Shukla Published on May 26, 2025, 09:56 IST Anupam Rasayan India saw its shares rise by over 3% in morning trading following the release of its Q4 FY25 consolidated financial results. As of 9:52 AM, the shares were trading 3.88% higher at Rs 975.15. The company reported a 24.7% increase in revenue, reaching Rs 500 crore compared to Rs 401 crore in the same period last year. EBITDA showed a significant rise of 55.8%, standing at Rs 144.3 crore against Rs 92.6 crore previously. The EBITDA margin improved to 28.9% from 23.1%. Net profit also grew by 44%, amounting to Rs 44.5 crore, up from Rs 30.9 crore year-on-year. These financial results indicate a strong performance for Anupam Rasayan in the fourth quarter of FY25. As of the time of writing, Anupam Rasayan India shares are open at ₹979.10, reaching a high of ₹983.20 and a low of ₹946.30. The stock has shown strong performance over the past year, reaching a 52-week high of ₹983.20 and a low of ₹601.00. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at
